Literature DB >> 7780101

Disseminated Mycobacterium genavense infection in Canadian AIDS patients.

S D Shafran1, G D Taylor, J A Talbot.   

Abstract

Mycobacterium genavense is a recently described mycobacterial species which thus far has been identified only in persons with advanced HIV disease. It appears to be a rare pathogen with an undefined reservoir. We describe the first two cases of M. genavense infection in Canadian AIDS patients. The clinical presentation of fever and wasting with extremely low CD4 lymphocyte counts was indistinguishable from disseminated M. avium complex (MAC) infection. However, blood cultures in BACTEC 13A medium required a mean of 58 days (range 41-87) to detect growth of M. genavense in contrast to a mean of 10 days for MAC in our laboratory. M. genavense infection is underdiagnosed due to the lack of universal use of BACTEC liquid medium and the use of relatively short incubation times (only 6 weeks) by some laboratories. The value of antimycobacterial therapy for M. genavense is unknown, but anecdotal data suggest that treatment with a regimen appropriate for MAC may be beneficial.

Entities:  

Mesh:

Year:  1995        PMID: 7780101     DOI: 10.1016/0962-8479(95)90562-6

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  6 in total

1.  Use of gas chromatographic fatty acid and mycolic acid cleavage product determination to differentiate among Mycobacterium genavense, Mycobacterium fortuitum, Mycobacterium simiae, and Mycobacterium tuberculosis.

Authors:  S Chou; P Chedore; S Kasatiya
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

2.  Disseminated infection with Mycobacterium genavense: a challenge to physicians and mycobacteriologists.

Authors:  V O Thomsen; U B Dragsted; J Bauer; K Fuursted; J Lundgren
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

3.  Inhibitory effects of polyoxyethylene stearate, PANTA, and neutral pH on growth of Mycobacterium genavense in BACTEC primary cultures.

Authors:  L Realini; P Van Der Stuyft; K De Ridder; B Hirschel; F Portaels
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

4.  Differentiation of Mycobacterium genavense and Mycobacterium simiae by automated mycolic acid analysis with high-performance liquid chromatography.

Authors:  D Ritter; L D Carlson; B K Logan; L S Ramos; J O Kilburn; M B Coyle
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

5.  Mycobacterium genavense infections in pet animals.

Authors:  T E Kiehn; H Hoefer; E C Bottger; R Ross; M Wong; F Edwards; N Antinoff; D Armstrong
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

Review 6.  Mycobacterium genavense in AIDS patients, report of 24 cases in Italy and review of the literature.

Authors:  E Tortoli; F Brunello; A E Cagni; D Colombrita; D Dionisio; L Grisendi; V Manfrin; M Moroni; C Passerini Tosi; G Pinsi; C Scarparo; M T Simonetti
Journal:  Eur J Epidemiol       Date:  1998-04       Impact factor: 8.082

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.